Nav: Home

New guidelines for treatment and management of COPD exacerbations

March 15, 2017

A multi-disciplinary task force of chronic obstructive pulmonary disease (COPD) experts has published comprehensive new guidelines on the treatment of COPD exacerbations, providing new advice on the treatment of exacerbations in outpatients and the initiation of pulmonary rehabilitation during or after an exacerbation of COPD, among other topics.

The European Respiratory Society (ERS) and American Thoracic Society (ATS) collaborated to develop the new guidelines, published today (16 March 2017) in the European Respiratory Journal. Chronic obstructive pulmonary disease (COPD) is a long-term condition that causes inflammation in the lungs, damaged lung tissue and a narrowing of the airways, making breathing difficult. The World Health Organization (WHO) predicts that COPD will become the third leading cause of death worldwide by 2030.

Previous guidelines have relied on evidence gathered mostly from patients hospitalised with severe exacerbations but the new document covers antibiotic and corticosteroid therapy for outpatients who experience mild and moderate exacerbations. The recommendations for outpatient care also include starting pulmonary rehabilitation 3 weeks after discharge from hospital following a severe exacerbation.

In addition, the paper provides recommendations related to non-invasive ventilation treatment and home-based management, and is centred on six key questions:
  • Oral corticosteroids versus. no corticosteroids for non-hospitalised patients
  • Oral corticosteroids vs. intravenous corticosteroids for hospitalised patients
  • Antibiotics vs. no antibiotics for ambulatory patients
  • Non-invasive mechanical ventilation vs. usual care for hospitalised patients
  • Home-based management vs. hospitalisation
  • Pulmonary rehabilitation vs. usual care for hospitalised patients
Professor Jadwiga Wedzicha, lead author of the guideline and editor-in-chief of the American Journal of Respiratory and Critical Care Medicine, commented: "Our guideline provides new recommendations based on more solid evidence for established therapies and including populations of patients that were not significantly represented in previous guidelines. The recommendations cover the different kinds of drugs and therapies that can be used at home and in a hospital setting, answering new questions for healthcare professionals."

Dr Marc Miravitlles, the ERS Guidelines Director and co-author of the new guideline, commented: "This new guideline can help improve the management of exacerbations in patients with COPD. The recommendations include new advice for general practitioners as they refer to ambulatory patients who may experience mild or moderate exacerbations. In addition, we provide new evidence to effective strategies, such as pulmonary rehabilitation, which has been shown to improve the outcomes of exacerbated COPD patients."

The evidence used to shape each debate was subject to comprehensive analysis using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach.

Each question is broken down in to sub-sections to detail a summary of the evidence, benefits, harms, further considerations, conclusions and research needs, wider expert opinions, ERS/ATS recommendation, remarks, and values and preferences.

The authors of the task force state that more detailed studies should be carried out in several of the areas discussed in the paper, to enable a more comprehensive set of guidelines be produced. They also state that recommendations should be reconsidered when new evidence becomes available.
-end-
Title: Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society (ERS/ATS) guideline

European Lung Foundation

Related Copd Articles:

Treatment seeks to address exacerbations of COPD
A new study finds that delivery of oxygen via high-flow nasal tubes may help patients who experience exacerbations of chronic obstructive pulmonary disease (COPD).
Study reveals surprises concerning COPD and smoking
A new study challenges the widely accepted but oversimplified description of airway inflammation in smokers and patients with chronic obstructive pulmonary disease (COPD).
New guidelines for treatment and management of COPD exacerbations
A multi-disciplinary ERS/ATS task force of chronic obstructive pulmonary disease (COPD) experts has published comprehensive new guidelines on the treatment of COPD exacerbations.
New genetic markers for COPD discovered
In a new Research Letter published in Nature Genetics on Feb.
COPD -- what causes the lungs to lose their ability to heal?
In chronic obstructive pulmonary disease (COPD), the patients' lungs lose their ability to repair damages on their own.
New technology detects COPD in minutes
Pioneering research by Professor Paul Lewis of Swansea University's Medical School into one of the most common lung diseases in the UK, Chronic Obstructive Pulmonary Disease, has led to the development of a new technology that can quickly and easily diagnose and monitor the condition.
COPD exacerbations lead to lung function decline, particularly among those with mild COPD
Acute exacerbations of chronic obstructive pulmonary disease, or COPD, are associated with significant long-term lung function loss, according to research published online, ahead of print in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.
Depression decreases adherence to COPD maintenance medications
A recent study in the Annals of the American Thoracic Society found that in a nationally representative sample of Medicare beneficiaries who were newly diagnosed with COPD, adherence to maintenance medications decreased with new episodes of depression.
Care for COPD: Could more be done?
Meilan Han, M.D., an associate professor of internal medicine at the University of Michigan and the medical director of the U-M Women's Respiratory Health Program, is the lead author on a new report that set out to provide a comprehensive view of COPD care in the US.
COPD symptoms common among smokers, even when undiagnosed
A new study in the New England Journal of Medicine finds that smokers, who wouldn't typically be diagnosed with chronic obstructive pulmonary disease, or COPD, are still showing symptoms consistent with the diagnosis.

Related Copd Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...